Egan KB. The epidemiology of benign prostatic hyperplasia associated with lower urinary tract symptoms. Urol Clin N Am. 2016;43(3):289–97.

Article  Google Scholar 

Parsons JK, Bergstrom J, Silberstein J, Barrett-Connor E. Prevalence and characteristics of lower urinary tract symptoms in men aged ≥80 years. Urology. 2008;72(2):318–21.

Article  PubMed  Google Scholar 

Solvang M, Elnegaard S, Jarbøl DE. Urological symptoms among 23,240 men in the general danish population - concerns about symptoms, their persistence and influence on primary care contacts. Scand J Prim Health Care. 2018;36(3):227–36.

Article  PubMed  PubMed Central  Google Scholar 

D’Ancona C, Haylen B, Oelke M, Abranches-Monteiro L, Arnold E, Goldman H, et al. The International Continence Society (ICS) report on the terminology for adult male lower urinary tract and pelvic floor symptoms and dysfunction. Neurourol Urodyn. 2019;38(2):433–77. Include the comprehensive and updated report that defined the subjective and objective pathologies used to this study and their criteria.

Article  PubMed  Google Scholar 

Taylor BC, Wilt TJ, Fink HA, Lambert LC, Marshall LM, Hoffman AR, et al. Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: the MrOS study. Urology. 2006;68(4):804–9.

Article  PubMed  Google Scholar 

Wong SYS, Hong A, Leung J, Kwok T, Leung PC, Woo J. Lower urinary tract symptoms and depressive symptoms in elderly men. J Affect Disord. 2006;96(1):83–8.

Article  PubMed  Google Scholar 

Wei JT, Calhoun E, Jacobsen SJ. Urologic diseases in america project: benign prostatic hyperplasia. J Urol. 2005;173(4):1256–61.

Article  PubMed  Google Scholar 

Rule AD, Jacobson DJ, Roberts RO, Girman CJ, McGree ME, Lieber MM, et al. The association between benign prostatic hyperplasia and chronic kidney disease in community-dwelling men. Kidney Int. 2005;67(6):2376–82. This is the most comprehensive and updated study to examine the consequences of BOO and LUTS regarding to kidney damage.

Article  PubMed  Google Scholar 

Jacobsen SJ, Jacobson DJ, Girman CJ, Roberts RO, Rhodes T, Guess HA, et al. Natural history of prostatism: risk factors for acute urinary retention. J Urol. 1997;158(2):481–7.

Article  CAS  PubMed  Google Scholar 

Armitage JN, Sibanda N, Cathcart PJ, Emberton M, van der Meulen JHP. Mortality in men admitted to hospital with acute urinary retention: database analysis. BMJ. 2007;335(7631):1199–202.

Article  PubMed  PubMed Central  Google Scholar 

Wadie BS, Ebrahim EHE, Gomha MA. The relationship of detrusor instability and symptoms with objective parameters used for diagnosing bladder outlet obstruction: a prospective study. J Urol. 2002;168(1):132–4.

Article  PubMed  Google Scholar 

Oelke M, Baard J, Wijkstra H, de la Rosette JJ, Jonas U, Höfner K. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia. Eur Urol. 2008;54(2):419–26.

Article  PubMed  Google Scholar 

Kang MY, Ku JH, Oh SJ. Non-invasive parameters predicting bladder outlet obstruction in korean men with lower urinary tract symptoms. J Korean Med Sci. 2010;25(2):272–5.

Article  PubMed  PubMed Central  Google Scholar 

Porru D, Jallous H, Cavalli V, Sallusto F, Rovereto B. Prognostic value of a combination of IPSS, flow rate and residual urine volume compared to pressure-flow studies in the preoperative evaluation of symptomatic BPH. Eur Urol. 2002;41(3):246–9.

Article  CAS  PubMed  Google Scholar 

Blaivas JG, Forde JC, Davila JL, Policastro L, Tyler M, Aizen J, et al. Surgical treatment of detrusor underactivity: a short term proof of concept study. Int Braz J Urol. 2017;43(3):540–8. This study established the difference in outcomes between DU and BOO, and supports the use of urodynamic findings and their utility in the clinical decision making.

Article  PubMed  PubMed Central  Google Scholar 

Eckhardt MD, van Venrooij GEPM, Boon TA. Symptoms, prostate volume, and urodynamic findings in elderly male volunteers without and with LUTS and in patients with LUTS suggestive of benign prostatic hyperplasia. Urology. 2001;58(6):966–71.

Article  CAS  PubMed  Google Scholar 

EAU guidelines on the management of non-neurogenic male LUTS - diagnostic evaluation - Uroweb [Internet]. Uroweb - European Association of Urology. [cited 2022 Sep 13]. Available from: https://uroweb.org/guidelines/management-of-non-neurogenic-male-luts/chapter/diagnostic-evaluation. These guidelines include comprehensive review of many aspects and were used as comparison to our review.

Yiou R, Audureau E, Loche CM, Dussaud M, Lingombet O, Binhas M. Comprehensive evaluation of embarrassment and pain associated with invasive urodynamics. Neurourol Urodyn. 2015;34(2):156–60.

Article  PubMed  Google Scholar 

Ko KJ, Suh YS, Kim TH, Sung HH, Ryu GH, Lee KS. Diagnosing bladder outlet obstruction using the penile cuff test in men with lower urinary tract symptoms. Neurourol Urodyn. 2017;36(7):1884–9. This study demonstrates the utility of penile cuff test compared with PFS, in terms of costs, adverse events, and accuracy.

Article  PubMed  Google Scholar 

Onur R, Özden M, Orhan I, Kalkan A, Semercioz A. Incidence of bacteraemia after urodynamic study. J Hosp Infect. 2004;57(3):241–4.

Article  CAS  PubMed  Google Scholar 

Foon R, Toozs‐Hobson P, Latthe P. Prophylactic antibiotics to reduce the risk of urinary tract infections after urodynamic studies. Cochrane Database of Systematic Reviews [Internet]. 2012 [cited 2022 Sep 18];(10). Available from: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008224.pub2/full.

Porru D, Madeddu G, Campus G, Montisci I, Scarpa RM, Usai E. Evaluation of morbidity of multi-channel pressure-flow studies. Neurourol Urodyn. 1999;18(6):647–52.

Article  CAS  PubMed  Google Scholar 

Leitner L, Walter M, Sammer U, Knüpfer SC, Mehnert U, Kessler TM. Urodynamic investigation: a valid tool to define normal lower urinary tract function? PLoS ONE. 2016;11(10): e0163847.

Article  PubMed  PubMed Central  Google Scholar 

Nr S, Je S, Ap K. Artifacts and abnormal findings may limit the use of asymptomatic volunteers as controls for studies of multichannel urodynamics. Minerva urology and nephrology [Internet]. 2021 Oct [cited 2022 Dec 2];73(5). Available from: https://pubmed.ncbi.nlm.nih.gov/32638575/.

Nitti VW, Kim Y, Combs AJ. Correlation of the AUA symptom index with urodynamics in patients with suspected benign prostatic hyperplasia. Neurourol Urodyn. 1994;13(5):521–7 (discussion 527-529).

Article  CAS  PubMed  Google Scholar 

de la Rosette JJMCH, Witjes WPJ, Schäfer W, Abrams P, Donovan JL, Peters TJ, et al. Relationships between lower urinary tract symptoms and bladder outlet obstruction: results from the ICS-“BPH” study. Neurourol Urodyn. 1998;17(2):99–108.

Article  PubMed  Google Scholar 

Reddy SVK, Shaik AB. Non-invasive evaluation of bladder outlet obstruction in benign prostatic hyperplasia: a clinical correlation study. Arab J Urol. 2019;17(4):259–64. This study gave a recent view of the accuracy of few tests to diagnose BOO.

Article  PubMed  PubMed Central  Google Scholar 

Steele GS, Sullivan MP, Sleep DJ, Yalla SV. Combination of symptom score, flow rate and prostate volume for predicting bladder outflow obstruction in men with lower urinary tract symptoms. J Urol. 2000;164(2):344–8.

Article  CAS  PubMed  Google Scholar 

Hashim H, Elhilali M, Bjerklund Johansen TE, Abrams P. The immediate and 6-mo reproducibility of pressure–flow studies in men with benign prostatic enlargement. Eur Urol. 2007;52(4):1186–94.

Article  PubMed  Google Scholar 

Renganathan A, Cartwright R, Cardozo L, Robinson D, Srikrishna S. Quality control in urodynamics: analysis of an international multi-center study. Neurourol Urodyn. 2009;28(5):380–4.

Article  PubMed  Google Scholar 

XLewis AL, Young GJ, Selman LE, Rice C, Clement C, Ochieng CA, et al. Urodynamics tests for the diagnosis and management of bladder outlet obstruction in men: the UPSTREAM non-inferiority RCT. Health Technol Assess. 2020;24(42):1–122. This comprehensive and important study re-opens the discussion about the use and utility of PFS – which may have far-reaching consequences on this issue.

Article  PubMed  PubMed Central  Google Scholar 

Lerner LB, McVary KT, Barry MJ, Bixler BR, Dahm P, Das AK, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline part I—initial work-up and medical management. J Urol. 2021;206(4):806–17. These guidelines include comprehensive review of many aspects and were used as comparison to our review.

Article  PubMed  Google Scholar 

Arnolds M, Oelke M. Positioning invasive versus noninvasive urodynamics in the assessment of bladder outlet obstruction. Curr Opin Urol. 2009;19(1):55–62.

Article  PubMed  Google Scholar 

Jung JH, Cho SY, Yoo C, Oh SJ. Establishment of the novel cystoscopic classification for bladder trabeculation of neurogenic bladder. Urology. 2014;84(3):515–9.

Article  PubMed  Google Scholar 

Takahashi R, Takei M, Namitome R, Yamaguchi O, Eto M. Symptoms and noninvasive test parameters that clinically differentiate detrusor underactivity from bladder outlet obstruction without a pressure-flow-based diagnosis in men with lower urinary tract symptoms. Neurourol Urodyn. 2021;40(1):303–9. This big study includes the predictive value of many parameters and non-invasive tests to differentiate between DU and BOO. This can be used in clinical practice.

Article  PubMed  Google Scholar 

De Nunzio C, Autorino R, Bachmann A, Briganti A, Carter S, Chun F, et al. The diagnosis of benign prostatic obstruction: development of a clinical nomogram. Neurourol Urodyn. 2016;35(2):235–40.

Article  PubMed  Google Scholar 

Meigs JB, Barry MJ, Giovannucci E, Rimm EB, Stampfer MJ, Kawachi I. Incidence rates and risk factors for acute urinary retention: the health professionals followup study. J Urol. 1999;162(2):376–82.

Article  CAS  PubMed  Google Scholar 

Emberton M, Elhilali M, Matzkin H, Harving N, van Moorselaar J, Hartung R, et al. Symptom deterioration during treatment and history of AUR are the strongest predictors for AUR and BPH-related surgery in men with LUTS treated with alfuzosin 10 mg once daily. Urology. 2005;66(2):316–22.

Article  PubMed  Google Scholar 

Luciani LG, Mattevi D, Ravanelli D, Anceschi U, Giusti G, Cai T, et al. A novel nomogram based on initial features to predict BPH progression. Int J Environ Res Public Health. 2022;19(15):9738.